Drug treatment in lewy body dementia

Dementia and Geriatric Cognitive Disorders

Volumn 8, Issue 3, 1997, Pages 188-197

  Geroldi, Cristina ^a   Frisoni, Giovanni B ^a   Bianchetti, Angelo ^a   Trabucchi, Bianchetti ^a  

^a GERIATRIC RESEARCH GROUP   (Italy)

Author keywords

Dementia; L Dopa; Lewy body dementia; Neuroleptics; Parkinsonism; Psychosis

Indexed keywords

ANTIPARKINSON AGENT; CLOZAPINE; LEVODOPA; NEUROLEPTIC AGENT; TRAZODONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DELUSION; DEMENTIA; FEMALE; HALLUCINATION; HUMAN; LEWY BODY; MALE; MENTAL DISEASE; PARKINSONISM; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030939443     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106630     Document Type: Article

References (19)

1. Gibb WRG, Esiri MM, Lees AJ: Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1985;110:1131-1153.
2. Burkhardt CR, Filley CM, Kleinschmidt-De-Masters BK, de la Monte S, Norenberg MD, Schneck SA: Diffuse Lewy body disease and progressive dementia. Neurology 1988:38: 1520-1528.
3. Perry RH, Irving D, Blessed G, Fairbairn AF, Perry EK: Senile dementia of Lewy body type: A clinically and neuropatologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990:95:119-139.
4. McKeith I, Perry RH, Fairbaim AF, Jabeen S, Perry EK: Operational criteria for senile dementia of Lewy' body type (SLDT). Psychol Med 1992;22:911-922.
5. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E: Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-678.
6. Wilcock GK, Scott MI: Tacrine for senile dementia of Alzheimer's or Lewy body type. Lancet 1994:344:544.
7. Lawton MP, Brody EM: Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969:9: 179-186.
8. Katz S, Downs TD, Cash HR, Grolz RC: Progress in development of the Index of ADL. Gerontologist 1970;10:20-30.
9. Binetti G, Magni E, Padovani A, et al.: Neuropsychological heterogeneity in mild Alzheimer's disease. Dementia 1993;4:321-326.
10. Folstein MF, Folstein SE, McHugh PR: 'Mini Mental State': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
11. Hughes CP, Berg L: A new clinical scale for the staging of dementia. Bri Psychiatry 1982:140: 566-572.
12. Yesavage A: Therapeutic approaches to dysfunction of memory in old age; in Meier-Ruge W (ed): The Elderly Patients in General Practice. Karger, Basel, 1987.
13. Hachinski VC, Ililff LD, Zilhka E, et al: Cerebral blood flow in dementia. Arch Neurol 1975; 32:632-637.
14. Frisoni GB, Calabresi L, Geroldi C, et al: Apo-lipoprolein E e4 allele in Alzheimer's disease and vascular dementia. Dementia 1994:5:240-242.
15. Harrison RWS, McKeith IG: Senile dementia of Lewy body type. A review of clinical and pathological features: implication for treatment. Int J Geriatr Psychiatry 1995:10:919-926.
16. Williams SW, Byrne EJ, Stokes P: The treatment of diffuse Lewy body disease: A pilot study. Int J Geriatr Psychiatry 1993:8:731-739.
17. Lewy R, Eagger S, Griffiths M, Perry E, Hon-avar M, Dean A, Lantos P: Lewy body and response to tacrine in Alzheimer’s disease. Lancet 1994:343:176.
18. Beck BJ: Neuropsychialrie manifestations of diffuse Lewy body disease. J Geriatr Psychiatry Neurol 1995:8:189-196.
19. Chacko RC, Hurley RA, Jankovic J: Clozapine use in diffuse Lewy body disease, J Neuropsychiatry Clin Neurosci 1993:5:206-208.